C12N 2760/18351
Methods of production or purification of viral material
C12N2760/18351 (Methods of production or purification of viral material) appears on 3 US grants and 7 published applications in this corpus.
Search patents in C12N- Granted patents
- 3
- Published applications
- 7
- Assignees
- 9
- Inventors
- 34
- Latest grant
- 11 Jun 2013
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 2 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Glycolipid adjuvant compositions11 Jun 2013US 8,460,679 B2Zoetis LLC
- Recombinant human metapneumovirus and its use27 Apr 2010US 7,704,491 B2The United States of America as represented by the Department of Health and Human Services
- Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus27 Apr 2010US 7,704,720 B2MedImmune, LLC
- Avian metapneumovirus isolates and immunogenic compositions therefrom20 Aug 2026US 2026/0240983 A1Iowa State University Research Foundation, Inc.
- Respiratory virus combination vaccines4 Jul 2024US 2024/0216500 A1ModernaTX, Inc.
- Production of viral vaccines on an avian cell line24 Feb 2022US 2022/0054618 A1
- Serum-Free Virus Propagation Platform For A Virus Vaccine Candidate3 Mar 2011US 2011/0053248 A1MedImmune, LLC
- Novel glycolipid adjuvant compositions23 Aug 2007US 2007/0196384 A1Zoetis LLC
Most cited
By later US patents
- Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus27US 7,704,720 B2MedImmune, LLC · 2010
- Recombinant human metapneumovirus and its use9US 7,704,491 B2The United States of America as represented by the Department of Health and Human Services · 2010
- Glycolipid adjuvant compositions5US 8,460,679 B2Zoetis LLC · 2013